Patents
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
09/2006
09/05/2006USRE39263 2-2-fluoro-5-ethylsulphonylamino-4-thiocarbamoyl-phenyl)-5,6,7,8-tetrahydro-1,2,4triazolo[4,3-a]pyridin-3(2H)-one; post or preemergent
09/05/2006US7102017 Processes to prepare small molecular thiophene compounds
09/05/2006US7102016 Preparation of 2,2′-di(3,4-ethylenedioxythiophene)s
09/05/2006US7102009 For treating cancer and angiogenesis-related disorders
09/05/2006US7102007 Dihydroindole and tetrahydroquinoline derivatives
09/05/2006US7101898 Amides of aminoalkyl-substituted azetidines, pyrrolidines, piperidines and azepanes
09/05/2006US7101893 Treating hyperproliferative disorders; N-(4-trifluoromethoxyphenyl) 3-[(quinolin-4-ylmethyl)amino]thiophene-2-carboxamide
09/05/2006US7101892 2-(4-benzenesulfonyl-4-methyl-pentyl)-5-phenyl-2-aza-bicyclo[2.2.1]heptane; useful for treating sleep disorder, depression, anxiety
09/05/2006US7101875 E.g., 4-(2-(1-Benzhydryl-2-(2-((benzylsulfonyl)amino)ethyl)-5-chloro-1H-indol-3 -yl)ethoxy)benzoic acid; inhibitors of phospholipase enzymes, esp. phospholipase A2; antiarthritic and -inflammatory agents; analgesics; rheumatoid diseases
09/05/2006US7101868 A 2-(((4-fluorophenyl)methyl)amino)-3-pyridinecarboxamide derivatives for treating cancer, angiogenesis, tumor
09/05/2006US7101867 Benzofuran derivatives, their production and use
08/2006
08/31/2006WO2006091674A1 Pgd2 receptor antagonists for the treatment of inflammatory diseases
08/31/2006WO2006091592A1 Naphthalene derivatives as modulators of the glucocorticoid receptor
08/31/2006WO2006091428A2 Heteroaryl substituted pyrazinyl-piperazine-piperidines with cxcr3 antagonist activity
08/31/2006WO2006090920A1 ACTIVATOR FOR PEROXISOME PROLIFERATOR ACTIVATING RECEPTOR δ
08/31/2006WO2006090915A1 Pyridyl acetic acid compounds
08/31/2006WO2006090853A1 Nitrogenous heterocyclic compound and medicinal use thereof
08/31/2006WO2006090817A1 Indole compound and use thereof
08/31/2006WO2006090234A1 Heterocyclic derivatives as cell adhesion inhibitors
08/31/2006WO2006089909A1 Novel antithrombotic substituted pyrrolidinones, the production and use thereof in the form of medicaments
08/31/2006WO2006089872A1 Glucopyranosyl-substituted ( (hetero)arylethynyl-benzyd-benzene derivatives and use thereof as sodium-dependent glucose cotransporter 2 (sglt2) inhibitors
08/31/2006WO2006078287A9 Pde4b inhibitors and uses therefor
08/31/2006WO2006072393A3 Sulfonyl pyrrolidines, method for producing the same and their use as drugs
08/31/2006WO2006066896A3 Pyrrolidine derivatives for the treatment of a disease depending on the activity of renin
08/31/2006WO2006066133A3 Histone deacetylase inhibitors
08/31/2006WO2006060029A3 Insecticidal n-substituted sulfoximines
08/31/2006WO2006035068A3 Hiv inhibiting 5-carbo- or heterocyclic substituted pyrimidines
08/31/2006WO2005051937A8 4-oxo-4,5-dihydro-furan-2-carboxylic and acid derivatives and methods of treatment of metabolic-related disorders thereof
08/31/2006WO2005035507A3 4-aminopyrimidine derivatives for treatment of hyperproliferative disorders
08/31/2006US20060194971 Anethole dithiolethione and other dithiolethiones for the treatment of conditions associated with dysfunction of monoamine neruotransmission
08/31/2006US20060194865 G-lactam derivatives as prostaglandin agonists
08/31/2006US20060194848 Substituted amine derivatives and methods of use
08/31/2006US20060194843 4-(2,6-Dichloro-benzoylamino)-1H-pyrazole-3-carboxylic acid piperidin-4-ylamide; anticancer agents; carcinoma of the colon; antifungal agents; antitumor agents; infections; 4-(2,6-difluoro-benzoylamino)-1H-pyrazole-3-carboxylic acid (1-methyl-piperidin-4-yl)-amide
08/31/2006US20060194834 Serotonin receptor antagonist; psychological disorders; Alzheimer's disease
08/31/2006US20060194818 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
08/31/2006US20060194817 N-{(1S,2R)-1-(3,5-difluorobonzyl)-2-hydroxy-3-[(3-iodobonzyl)amino]propyl}-2-{4-[(methylsulfonyl)amino]phenyl}acetamide; inhibitors of the beta- secretase enzyme useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide in a mamma
08/31/2006US20060194809 Heteroaryl 5-thio-beta-d-gucopyranoside derivatives and therapeutic agents for diabetes containing the same
08/31/2006US20060194805 Capsaicin receptor agonists
08/31/2006US20060194803 anti-dementia agent which uses a BEC 1 potassium channel inhibitor as the active ingredient; to improve learning disorder
08/31/2006US20060194798 Bicyclic-substituted amines as histamine-3 receptor ligands
08/31/2006US20060194795 Platelet ADP receptor inhibitors
08/31/2006US20060194793 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
08/31/2006US20060194792 1-Cyclic carbonyl-4-(4-quinoline-)-1,4-diazepine or 1-cyclic carbonyl-4-[4-(1H-quinolin-2-{thio}one)-1,4-diazepinone derivatives; retinopathy, adult respiratory distress syndrome, asthma, osteoarthritis, glomerulonephritis, psoriasis, rheumatoid arthritis, and toxic shock syndrome treatment
08/31/2006US20060194787 substituted 1,1,4-1l6-trioxo[1,2]thiazepan-4-ylamide-derived protease inhibitors which inhibit the likes of cathepsin K; treating osteoporosis, osteo- and rheumatoid arthritis and periodontal disease; inhibiting excessive cartilage or matrix degradation
08/31/2006US20060194781 Alkyl ether derivatives or salts thereof
08/31/2006US20060194778 Serotonin receptor antagonist; psychological disorders; side effect reduction
08/31/2006US20060194772 Triamide-substituted heterobicyclic compounds
08/31/2006CA2599454A1 Activator for peroxisome proliferator activating receptor d
08/31/2006CA2599348A1 Indole compound and use thereof
08/31/2006CA2599021A1 Novel antithrombotic substituted pyrrolidinones, the production and use thereof in the form of medicaments
08/31/2006CA2598934A1 Pyridyl acetic acid compounds
08/31/2006CA2598418A1 Heteroaryl substituted pyrazinyl-piperazine-piperidines with cxcr3 antagonist activity
08/31/2006CA2598133A1 Pgd2 receptor antagonists for the treatment of inflammatory diseases
08/31/2006CA2595257A1 Glucopyranosyl-substituted ((hetero)arylethynyl-benzyl)-benzene derivatives and use thereof as sodium-dependent glucose cotransporter 2 (sglt2) inhibitors
08/30/2006EP1695964A1 Quinoline derivatives for use as intermediates in the synthesis of heterocyclylalcoyl piperidines
08/30/2006EP1695962A1 Cyclic amine derivative having heteroaryl ring
08/30/2006EP1695705A1 Compounds effecting glucokinase
08/30/2006EP1694686A1 Kinase inhibitors
08/30/2006EP1694670A1 Pyrazine derivatives as effective compounds against infectious diseases
08/30/2006EP1694669A2 Novel compounds which are modulators of the ppar-type receptors and their use in cosmetic or pharmaceutical compositions
08/30/2006EP1694668A1 4-[(arylmethyl)aminomethyl]piperidine derivatives, preparation thereof and application of same in therapeutics
08/30/2006EP1694665A2 Substituted thiophenes
08/30/2006EP1694653A1 Substituted 6-cyclohexylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors
08/30/2006EP1694650A1 1-n-phenyl-amino-1h-imidazole derivatives and pharmaceutical compositions containing them
08/30/2006EP1694649A1 2-pyridinylethylcarboxamide derivatives and their use as fungicides
08/30/2006EP1694643A1 Carboxamide derivatives
08/30/2006EP1694638A1 N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof
08/30/2006EP1694410A2 Cyclopropane compounds and pharmaceutical use thereof
08/30/2006EP1694334A1 Tetrahydrobenzazepines and their use in the modulation of the dopamine d3 receptor
08/30/2006EP1694327A2 Novel m3 muscarinic acetylcholine receptor antagonists
08/30/2006EP1505966A4 1,1-disubstituted cycloalkyl derivatives as factor xa inhibitors
08/30/2006EP1487813B1 Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders
08/30/2006EP1345924B1 Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use
08/30/2006EP1335722B1 Indolyl-sulfonyl- compounds useful in the treatment of cns disorders
08/30/2006CN1826330A Combretastatin derivatives with cytotoxic action
08/30/2006CN1826325A 4,5-dihydro-imidazole as P2X7 ion channel blockers
08/30/2006CN1826324A Indazole, benzisoxazole, and benzisothiazole kinase inhibitors
08/30/2006CN1826323A 3,4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators
08/30/2006CN1826321A Quinolone derivative or its salt
08/30/2006CN1826317A 酪氨酸激酶抑制剂 Tyrosine kinase inhibitor
08/30/2006CN1824662A Substituted pyridine herbicides
08/30/2006CN1272324C Novel herbicides
08/30/2006CN1272316C Benzamides and related inhibitors of factor Xa
08/29/2006US7098340 Quinoline/chromene derivatives as androgen antagonist
08/29/2006US7098330 Pyrazolylamine substituted quinazoline compounds useful as protein kinase inhibitors
08/29/2006US7098241 Thiophene hydroxamic acid derivatives
08/29/2006US7098240 Compounds
08/29/2006US7098239 Dipeptidyl peptidase inhibitors for the treatment of diabetes
08/29/2006US7098234 Indole derivatives, process for preparation of the same and use thereof
08/29/2006US7098231 Viral polymerase inhibitors
08/29/2006US7098226 E.g., 1-(2-(1-adamantyl)ethyl)-1-pentyl-3-(3-(4-pyridyl)propyl)urea; useful as therapeutic agents for autoimmune diseases such as rheumatoid arthritis.
08/29/2006US7098223 Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain
08/29/2006US7098222 Bicyclic-substituted amines having cyclic-substituted monocyclic substituents
08/29/2006US7098215 Nitrogenous compounds and antiviral drugs containing the same
08/29/2006US7098213 three-ring saturated N-heterocyclic compounds in combination with one or more antiviral or other agents; in immunotherapy
08/29/2006US7098212 Piperazine derivatives
08/29/2006US7097706 non-calcined clay composite includes clay, lime, blast furnace slag, alkaline chemical, and water in specified amounts, and has high compression strength due to an ionic coagulation reaction, a pozzolan reaction, and a latent hydraulic reaction
08/29/2006CA2396738C Thiazole derivatives as active superoxide radical inhibitors
08/24/2006WO2006089060A1 Fungicidal pyrazine derivatives
08/24/2006WO2006088920A1 Amine-linked pyridyl and phenyl substituted piperazine-piperidines with cxcr3 antagonist activity